TCG Crossover Management »

Entrada Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $9.2M 585k 15.80
2023-06-30 $8.9M 585k 15.14
2023-03-31 $8.5M 585k 14.50
2022-12-31 $7.9M 585k 13.52
2022-09-30 $10M 642k 15.76
2022-06-30 $8.1M 664k 12.18
2022-03-31 $6.1M 664k 9.24
2021-12-31 $11M 664k 17.12